R-CHOP Dose Intensity and Survival Outcomes in DLBCL
Chan Yoon Cheah, MBBS, discusses the results of a systematic review investigating the impact of R-CHOP dose intensity on survival outcomes in patients with DLBCL.
IELSG30: Treating Primary Testicular DLBCL
Dr Annarita Conconi summarizes the results of the Phase II IELSG30 trial assessing R-CHOP, intravenous methotrexate, liposomal cytarabine, and scrotal irradiation in patients with primary DLBCL of the testis.
Sequencing Treatment Options in Primary Refractory DLBCL
Davies begins by outlining a specific patient case, caveats in the current treatment options for DLBCL, and the patterns of primary refractory DLBCL.
First-in-Human Trial of ALLO-501A in R/R Large B-cell Lymphoma
Dr Michael Tees discusses the first-in-human data of ALLO-501A, an allogeneic CAR-T product under investigation in relapsed/refractory large B-cell lymphoma in the ALPHA2 study.
The Influence of the TME on Progression and Outcomes in Follicular Lymphoma
Dr Jessica Okosun gives an overview of current knowledge regarding the influence of the tumor microenvironment on disease progression and outcomes in follicular lymphoma.
Management of Relapse Post-alloHSCT in Patients With B-Cell Lymphoma
Dr Peter Dreger discusses treatment strategies that can be used in patients with B-cell lymphomas relapsing following allogeneic hematopoietic stem cell transplantation.
Satellite Symposium | Roundtable Discussion, Summary, and Conclusions
At the 16-ICML, the Lymphoma Hub hosted a virtual satellite symposium on the sequencing of therapies in high-risk relapsed/refractory lymphoma.
The Relevance of Follicular Lymphoma Pathogenesis in Clinical Practice
Dr Jessica Okosun gives an overview of the molecular pathogenesis of follicular lymphoma, and its relevance in clinical practice.
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Relapsed/Refractory Follicular Lymphoma
Dr Stephen Schuster speaks to ecancer in an online interview for the ASCO 2021 virtual meeting about the ELARA study.
Dr Julie Vose from the University of Nebraska Medical Center presents a session on lymphoma treatment updates.
Lung Cancer + Radiation Oncology
Updates in Radiotherapy at ELCC 2021
In this discussion, Dr Umberto Ricardi outlines the latest developments in RT for patients with lung cancer, highlighting the ability to improve treatment of brain metastases with radiosurgery...
Advances in Radiation Therapy in Stage III NSCLC
Oncology specialists from a lung multidisciplinary team discuss challenges associated with radiation therapy in Stage III NSCLC.
Future Perspectives on Radiation Oncology in Lung Cancer
Dr Umberto Ricardi discusses the management of patients with lung cancer who have brain metastases and the importance of precision medicine in treating these patients.
Global Access to Radiotherapy for Lung Cancer
This webinar describes the current landscape and challenges to deliver RT for lung cancer, with an emphasis on low-and middle-income countries and geographically underserved regions of high-income countries.
Patterns of Relapse After Radiotherapy in SCLC and Future Treatment Strategies
Dr Sanjay Popat discusses the findings of a subset analysis of the CONVERT trial investigating patterns of relapse following thoracic radiotherapy in patients with limited-stage SCLC.
Expert Roundtable: The Management and Care of EGFR Patients
In part three of this virtual roundtable discussion, moderated by Dr Edgardo Santos, a panel of experts sat down with Oncology Learning Network to discuss the management and care of EGFR patients.<
Dr Andrew Armstrong on Precision Medicine Approaches in Advanced Prostate Cancer
In this video, Dr Andrew Armstrong discusses various precision medicine approaches in advanced prostate cancer treatment.
Prostate Cancer and Immunotherapy With Dr. Ana Aparicio
Dr Ana Aparicio discusses scientific and clinical research for prostate cancer treatment, as well as biomarkers and genomic sequencing, combination therapies, clinical trials, and side effects.
Practice-Changing Data From ESMO 2021 in Prostate Cancer
Dr Robert Jones gives his thoughts on practice-changing data from the recent ESMO 2021 meeting.
10 Warning Signs of Prostate Cancer
In its early stages, the disease rarely causes symptoms, but you may experience certain warning signs as it progresses. Here’s what to be on the lookout for.
Prostate Risk Factors and Treatment
While there are several things that can increase the risk of developing prostate cancer it can also happen spontaneously, so it is very important for men to be screened.
Sickle Cell Anemia
Clinical Research and Sickle Cell Disease
This discussion explores issues in sickle cell disease clinical research from the participant's perspective.
Sickle Cell Disease and COVID-19
Dr John Whyte speaks with Dr Wanda Whitten-Shurney, CEO and Medical Director of the Michigan Chapter of the SCDAA, and Clifton R. Kirkman II, a sickle cell warrior, about the impact...
Sickle Cell Disease: Ask Dr Susmita Sarangi
Dr Susmita Sarangi is a pediatric hematologist/oncologist in the MedStar Georgetown University Hospital Division of Pediatric, Adolescent, and Young Adult Hematology and Oncology.
Sickle Cell Disease Overview
Dr Kerry Morrone discusses what causes sickle cell disease, the signs, and symptoms and how to diagnosis it.
NHS Approves 'Life Changing' Sickle Cell Disease Drug
A new treatment for sickle cell disease has been hailed as a "revolution" for sufferers. The condition is serious and lifelong and can cause severe pain and organ failure - and those who have it end up in hospital often.
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz
Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.